KALV·483497103·US·Common Stock·Healthcare - Biotechnology-Activist
KALV (KALVISTA PHARMACEUTICALS INC) is held by 92 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($76.4M), Capital World Investors ($56.5M), Point72 Asset Management, L.P. ($43M). Net institutional sentiment: Mixed.
Showing 1-20 of 99
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer